The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis
Takuma Narita(Hirosaki University), Chikara Οhyama(Hirosaki University), Hayato Yamamoto(Hirosaki University), Sadafumi Kawamura(Miyagi Prefectural Hospital Organization), Shintaro Narita(Akita University), Takuya Koie(Hirosaki University), Takamitsu Inoue(International University of Health and Welfare), Koji Mitsuzuka(Pacific Northwest Diabetes Research Institute), Yoichi Arai(Japan Atomic Energy Agency), Shingo Hatakeyama(Hirosaki University), Teppei Ookubo(Tohoku University), Tatsuo Tochigi(Miyagi Prefectural Hospital Organization), Tomonori Habuchi(Akita University)
Cited by 49
Related Papers
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Prospective Randomized Phase II Trial of a Single Early Intravesical Instillation of Pirarubicin (THP) in the Prevention of Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: The THP Monotherapy Study Group Trial
|Journal of Clinical Oncology|2013|253
Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract.
|PubMed|1998|176
ANATOMICAL ANALYSIS OF THE NEUROVASCULAR BUNDLE SUPPLYING PENILE CAVERNOUS TISSUE TO ENSURE A RELIABLE NERVE GRAFT AFTER RADICAL PROSTATECTOMY
|The Journal of Urology|2004|159
Prognostic Significance of Prostate Specific Antigen in Endocrine Treatment for Prostatic Cancer
|The Journal of Urology|1990|122